Markman Advisors assists companies with valuing portfolios of patents, either for internal uses or within the M&A context. We deploy a proprietary set of 15 to 20 unique metrics that stress-test the strength of patents and determine their monetary value.
Unlike other patent valuation firms, we do not rely upon commonly-used metrics for valuing patents, such as forward and backward citations. These are weak indicators of a patent’s true value. Instead, we bring our first-hand experience as litigators to assessing the strengths and weaknesses of patents, as well as the likely scope of damages, that other patent-valuations services typically miss (including issues related to Alice, Nautilus, IPXL, joint-infringement, among others.)
Please contact us to learn more about our patent valuation services. Prior valuation reports (which have been excerpted and redacted) are available for viewing.
Case Study: Acting on behalf of Crossroads Systems, Inc. ($CRDS), Markman Advisors (through its sister law firm) conducted a valuation and action plan of Crossroads’ “non-972” patent portfolio, which included an in-depth analysis of 120+ patents. See Crossroads’ August 19, 2014 press release here.